Effectiveness of subcutaneous dihydroergotamine by home injection for migraine

Headache

Volumn 36, Issue 3, 1996, Pages 144-148

  Becker, W J ^a,b   Riess, C M ^a   Hoag, J ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b Calgary General Hospital   (Canada)

Author keywords

at home treatment; dihydroergotamine (DHE); migraine headache; subcutaneous injection

Indexed keywords

DIHYDROERGOTAMINE;

ARTICLE; CHRONIC PAIN; CLINICAL TRIAL; DRUG EFFICACY; FOLLOW UP; HEADACHE; HOME CARE; HUMAN; INJECTION SITE; LEG PAIN; MAJOR CLINICAL STUDY; MIGRAINE; NAUSEA; PAIN; PARESTHESIA; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; THORAX PAIN; TREATMENT OUTCOME; VOMITING;

ADULT; ANALGESICS, NON-NARCOTIC; DIHYDROERGOTAMINE; FEMALE; HOME NURSING; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; RETROSPECTIVE STUDIES; SELF ADMINISTRATION;

EID: 0029919117     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.1996.3603144.x     Document Type: Article

References (13)

1. Raskin NH. Repetitive intravenous dihydroergotamine as therapy for intractable migraine. Neurology. 1986;36:995997.
2. Callaham M, Raskin N. A controlled study of dihydroergotamine in the treatment of acute migraine headache. Headache. 1986;26:168-171.
3. Belgrade MJ, Ling LJ, Schleevogt MB, Ettinger MG, Ruiz E. Comparison of single-dose meperidine, butorphanol, and dihydroergotamine in the treatment of vascular headache. Neurology. 1989;39:590-592.
4. Saadah HA. Abortive headache therapy in the office with intravenous dihydroergotamine plus prochlorperazine. Headache. 1992;32:143-146.
5. Saadah HA. Abortive headache therapy with intramuscular dihydroergotamine. Headache. 1992;32:18-20.
6. Winner P, Dalessio D, Mathew N, et al. Office-based treatment of acute migraine with dihydroergotamine mesylate. Headache. 1993;33:471-475.
7. Klapper JA, Stanton J. Clinical experience with patient administered subcutaneous dihydroergotamine mesylate in refractory headaches. Headache. 1992;32:21-23.
8. Weisz MA, el-Raheb M, Blumenthal HJ. Home administration of intramuscular DHE for the treatment of acute migraine headache. Headache. 1994;34:371-373.
9. Silberstein SD, Lipton RB, Solomon S, Mathew NT. Classification of daily and near-daily headaches: proposed revisions to the IHS criteria. Headache. 1994:34:1-7.
10. Wheeler SD. Dihydroergotamine local reactions reduced by normal saline. Neurology. 1993;43:1852.
11. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988;8(suppl 7):1-96.
12. Ziegler D, Ford R, Kriegler J, et al. Dihydroergotamine nasal spray for the acute treatment of migraine. Neurology. 1994;44:447-453.
13. Dihydroergotamine Nasal Spray Multicenter Investigators. Efficacy, safety, and tolerability of dihydroergotamine nasal spray as monotherapy in the treatment of acute migraine. Headache. 1995;35:177-184.